SCHEMBL8129343

SCHEMBL8129343

[CH2]Nc1n[nH]c(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8129348 0.75
SCHEMBL10769032 0.75
SCHEMBL10765717 0.68 MAOA (0.41)
SCHEMBL16253865 0.67 GAA (0.42)
SCHEMBL6744037 0.66 GAA (1.00)
SCHEMBL9818686 0.66 GAA (0.41)
SCHEMBL17742100 0.65 GAA (0.61)
Guanazole SCHEMBL15697 0.64
SCHEMBL3463283 0.64 GAA (0.37)
SCHEMBL10765724 0.63 KCNH3 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114390-A AN ARGININAMIDE OR ORNITHINAMIDE COMPOUND AS TREATING MEMORY LOSS, MIGRAINE, SLEEP DISORDERS, PAIN, CARDIOVASCULAR DISEASES, SUBARACHNOIDAL BLEEDING, VASCULAR-HYPERTROPHIC CHANGES, CEREBRAL AND CORONARY VASOSPASMS KARL THOMAE GMBH (DE) 2000-09-05 US disclosed